Orange, CA, United States of America

Gregory A Wright

This inventor holds 26 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in Bioprosthetic Tissue Engineering. Top assignee: Edwards Lifesciences Corporation. Active years: 1995-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory A Wright. Retrieved from https://idiyas.com/inventor/gregory-a-wright

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 377(Granted Patents)


Location History:

  • Franklin, NJ (US) (1995)
  • Orange, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 1995-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bioprosthetic Tissue
Heart Valve Delivery
Calcification Reduction
Prosthetic Heart Valve
Valve Conduit
Tissue Preparation
Implantation Methods
Pre-assembled Packaging
Conditioning Methods
Native Heart Valve Replacement
Capping Techniques
26 patents (USPTO):Explore Patents

Title: Innovations in Bioprosthetics: The Impact of Gregory A. Wright

Introduction

Gregory A. Wright is an accomplished inventor based in Orange, California, who has made significant contributions to the field of bioprosthetic devices. With a remarkable portfolio of 23 patents, his work primarily revolves around innovative methods for the development and application of bioprosthetic materials, particularly in cardiovascular solutions.

Latest Patents

Among his latest patents are groundbreaking inventions that focus on the methods of implanting a dry bioprosthetic valved conduit and conditioning sheet bioprosthetic tissue. The first invention features a valved conduit equipped with a bioprosthetic valve designed to be stored in a dry state without compromising its functionality. This device utilizes a bioresorbable medium, ensuring that the heart valve remains effective and safe for extended periods.

The second patent encompasses novel techniques for conditioning bioprosthetic materials, employing bovine pericardial membrane. This innovative method utilizes lasers or dermatomes to attain a uniform thickness and smoothness in the membrane, allowing for enhanced performance. It combines compression and cross-linking techniques to achieve strong yet thin membranes, ready for medical applications.

Career Highlights

Gregory A. Wright serves as a pivotal team member at Edwards Lifesciences Corporation, a leader in the development of heart valves and other advanced therapies. His expertise and contributions have positioned him at the forefront of innovative bioprosthetic technology, reflecting a commitment to improving patient outcomes in the healthcare sector.

Collaborations

Throughout his career, Gregory has collaborated with notable colleagues such as Jeffrey S. Dove and Louis A. Campbell. Their collective expertise and shared vision for advancing medical technologies continue to drive significant developments in bioprosthetics, expanding the possibilities for innovation in this essential field.

Conclusion

Gregory A. Wright's extensive work in bioprosthetic innovations highlights his role as a leading inventor in this field. His patents not only demonstrate a commitment to advancing medical technology but also illustrate the impact of collaboration and research in the pursuit of improved healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…